Eli Lilly (LLY) Intangibles (2016 - 2025)
Historic Intangibles for Eli Lilly (LLY) over the last 14 years, with Q3 2025 value amounting to $6.4 billion.
- Eli Lilly's Intangibles fell 138.59% to $6.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $6.4 billion, marking a year-over-year decrease of 138.59%. This contributed to the annual value of $6.2 billion for FY2024, which is 1071.87% down from last year.
- According to the latest figures from Q3 2025, Eli Lilly's Intangibles is $6.4 billion, which was down 138.59% from $5.9 billion recorded in Q2 2025.
- Eli Lilly's 5-year Intangibles high stood at $8.1 billion for Q1 2021, and its period low was $5.9 billion during Q2 2025.
- Over the past 5 years, Eli Lilly's median Intangibles value was $6.9 billion (recorded in 2023), while the average stood at $7.0 billion.
- Per our database at Business Quant, Eli Lilly's Intangibles skyrocketed by 413.43% in 2021 and then plummeted by 1109.11% in 2025.
- Quarter analysis of 5 years shows Eli Lilly's Intangibles stood at $7.7 billion in 2021, then dropped by 6.31% to $7.2 billion in 2022, then decreased by 4.16% to $6.9 billion in 2023, then decreased by 10.72% to $6.2 billion in 2024, then increased by 4.55% to $6.4 billion in 2025.
- Its last three reported values are $6.4 billion in Q3 2025, $5.9 billion for Q2 2025, and $6.0 billion during Q1 2025.